Loading clinical trials...
Loading clinical trials...
An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study
Conditions
Interventions
Psilocybin combined with Psychotherapy
Locations
1
Canada
MacAnxiety Research Centre
Hamilton, Ontario, Canada
Start Date
March 1, 2025
Primary Completion Date
March 1, 2026
Completion Date
June 1, 2026
Last Updated
March 19, 2025
NCT04902092
NCT04923230
Lead Sponsor
McMaster University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions